» Articles » PMID: 16932902

Long-term Follow-up of Patients with Idiopathic Infantile Hypercalcaemia

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2006 Aug 26
PMID 16932902
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Idiopathic infantile hypercalcaemia (IIH) is a rare disorder of unknown etiology that presents with hypercalcaemia in a child's first year of life. There is only a limited number of published reports of the natural history of this condition, and the long-term prognosis is largely unknown. The presentation, treatment and long-term follow-up of 11 children with IIH treated at our institution since 1993 are described. Hypercalcaemia resolved in the majority of children by the time they were 3 years of age, but nephrocalcinosis and persistent hypercalciuria were common, and, in some cases, urinary calcium excretion increased after initially becoming normal. This study suggests that clinical and biochemical abnormalities may persist for longer than previously reported and implies the need for ongoing surveillance of patients with IIH.

Citing Articles

Hereditary disorders of vitamin-D metabolism and its receptor.

Lainis V, Katsouli O, Gazi S, Kassi E, Chronopoulos E, Tournis S Hormones (Athens). 2025; .

PMID: 39893280 DOI: 10.1007/s42000-025-00630-w.


Phenotype of Idiopathic Infantile Hypercalcemia Associated with the Heterozygous Pathogenic Variant of and .

Bizerea-Moga T, Chisavu F, Ilies C, Olah O, Marginean O, Gafencu M Children (Basel). 2023; 10(10).

PMID: 37892364 PMC: 10605249. DOI: 10.3390/children10101701.


A Case of Delayed Diagnosis of Idiopathic Infantile Hypercalcemia Due to CYP24A1 Mutation: A 10-Year Journey.

Khan Z, Mlawa G, Yang Y, Mahamud B Cureus. 2023; 15(8):e42811.

PMID: 37664318 PMC: 10470664. DOI: 10.7759/cureus.42811.


Rifampin monotherapy for children with idiopathic infantile hypercalcemia.

Lenherr-Taube N, Furman M, Assor E, Thummel K, Levine M, Sochett E J Steroid Biochem Mol Biol. 2023; 231:106301.

PMID: 36990163 PMC: 10441173. DOI: 10.1016/j.jsbmb.2023.106301.


Idiopathic infantile hypercalcemia in children with chronic kidney disease due to kidney hypodysplasia.

Gurevich E, Borovitz Y, Levi S, Perlman S, Landau D Pediatr Nephrol. 2022; 38(4):1067-1073.

PMID: 36156733 DOI: 10.1007/s00467-022-05740-w.


References
1.
Schell-Feith E, Kist-van Holthe J, van Zwieten P, Zonderland H, Holscher H, Swinkels D . Preterm neonates with nephrocalcinosis: natural course and renal function. Pediatr Nephrol. 2003; 18(11):1102-8. DOI: 10.1007/s00467-003-1235-9. View

2.
Mizusawa Y, Burke J . Prednisolone and cellulose phosphate treatment in idiopathic infantile hypercalcaemia with nephrocalcinosis. J Paediatr Child Health. 1996; 32(4):350-2. DOI: 10.1111/j.1440-1754.1996.tb02569.x. View

3.
Karlowicz M, Adelman R . Renal calcification in the first year of life. Pediatr Clin North Am. 1995; 42(6):1397-413. DOI: 10.1016/s0031-3955(16)40090-8. View

4.
Pak C . Clinical pharmacology of sodium cellulose phosphate. J Clin Pharmacol. 1979; 19(8-9 Pt 1):451-7. DOI: 10.1002/j.1552-4604.1979.tb02507.x. View

5.
Rodd C, Goodyer P . Hypercalcemia of the newborn: etiology, evaluation, and management. Pediatr Nephrol. 1999; 13(6):542-7. DOI: 10.1007/s004670050654. View